Discontinued — last reported Q4 '23
Geographic · Property, plant, and equipment, net
Rest Of World — Property, plant, and equipment, net
Regeneron Pharmaceuticals Rest Of World — Property, plant, and equipment, net decreased by 3.9% to $771.40M in Q4 2023 compared to the prior quarter.
Analysis
StatementSegment
CategoryCapital Allocation
SignalContext dependent
VolatilityStable
First reportedQ4 2021
Last reportedQ4 2023
Rolls up toProperty, plant and equipment, net
How to read this metric
An increase suggests ongoing capital investment and expansion of physical capacity in international markets, while a decrease may indicate asset depreciation, divestment, or a shift toward outsourced manufacturing models.
Detailed definition
This metric represents the net book value of tangible long-term assets, such as manufacturing facilities, laboratories,...
Peer comparison
Peers in the pharmaceutical industry typically report similar geographic splits of property, plant, and equipment to demonstrate their global manufacturing footprint and supply chain resilience.
Metric ID:
regn_segment_rest_of_world_property_plant_and_equipment_netHistorical Data
3 periods
| Q4 '21 | Q4 '22 | Q4 '23 | |
|---|---|---|---|
| Value | $797.80M | $803.00M | $771.40M |
| QoQ Change | — | +0.7% | -3.9% |
| YoY Change | — | +0.7% | -3.9% |
Range$771.40M – $803.00M
Avg YoY Growth-1.6%
Median YoY Growth-1.6%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Regeneron Pharmaceuticals's rest of world — property, plant, and equipment, net?
- Regeneron Pharmaceuticals (REGN) reported rest of world — property, plant, and equipment, net of $771.40M in Q4 2023.
- What does rest of world — property, plant, and equipment, net mean?
- The net value of the company's physical assets, such as buildings and machinery, located outside of its home country.